Uncategorized

Pfizer Jumps On Mixed, But ‘Marginally Encouraging,’ Guidance – Investor’s Business Daily

Posted on Author Comments Off on Pfizer Jumps On Mixed, But ‘Marginally Encouraging,’ Guidance – Investor’s Business Daily
  1. Pfizer Jumps On Mixed, But ‘Marginally Encouraging,’ Guidance  Investor’s Business Daily
  2. Pfizer Shares Jump 4% on Positive 2025 Outlook Despite $1B Impact  Yahoo Finance
  3. Pfizer Sees 2025 Revenue in Line With Wall Street Views  The Wall Street Journal
  4. Pfizer Stock Rises as Drug Giant Sees 2025 Revenue of $61 Billion to $64 Billion  Barron’s
  5. Pfizer’s In-Line Guidance Offers Relief to Weary Investors  Bloomberg